Veronesi Study
About:
A new European study conducted by Dr. Umberto Veronesi, founder of the European Institute of Oncology, has recently announced that a single dose of intraoperative electron-beam radiation can be equal to the traditional six-week course for women with breast cancer. The only FDA-approved device available in North America that is capable of delivering the IOERT treatment extolled by Dr. Veronesi in an unshielded operating room is IntraOp’s Mobetron. The Mobetron is the first fully portable, self-shielded linear accelerator that can be used in an existing operating room.
Additional Resources
Veronesi’s study of 1200 breast cancer patients
Read the summary of Veronesi Results (powerpoint)
Umberto Veronesi
Six Weeks of Radiation Therapy May Be Unnecessary for Many Breast Cancer Patients from intraop medized on Vimeo.
Other documents
Read the latest brochure on IOERT for Breast Cancer
Read the latest Single Dose Treatment Brochure
Read about Nagoya University announces Single Dose Treatment for Women with Breast Cancer
Other US based institutions with the Mobetron that are or will be doing the single dose:
The Center for Breast Surgery at the Robert A. Gardner, M.D. Foundation
http://breastquestion.com/home.html
